Number of items: 2.
Collapse authors list.
Clarke, Caroline S, Hunter, Rachael M, Gabrio, Andrea, Brawley, Christopher D, Ingleby, Fiona C, Dearnaley, David P, Matheson, David, Attard, Gerhardt, Rush, Hannah L, Jones, Rob J ORCID: 0000-0001-5608-001X et al (show 12 more authors) , Cross, William, Parker, Chris, Russell, J Martin, Millman, Robin, Gillessen, Silke, Malik, Zafar, Lester, Jason F, Wylie, James, Clarke, Noel W, Parmar, Mahesh KB, Sydes, Matthew R and James, Nicholas D
(2022)
Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data.
PloS one, 17 (6).
e0269192-e0269192.
Collapse authors list.
Gillessen, Silke, Bossi, Alberto, Davis, Ian D, de Bono, Johann ORCID: 0000-0002-2034-595X, Fizazi, Karim, James, Nicholas D ORCID: 0000-0002-7314-8204, Mottet, Nicolas, Shore, Neal, Small, Eric, Smith, Mathew et al (show 108 more authors) , Sweeney, Christopher, Tombal, Bertrand, Antonarakis, Emmanuel S, Aparicio, Ana M, Armstrong, Andrew J, Attard, Gerhardt, Beer, Tomasz M, Beltran, Himisha, Bjartell, Anders, Blanchard, Pierre, Briganti, Alberto, Bristow, Rob G, Bulbul, Muhammad, Caffo, Orazio, Castellano, Daniel, Castro, Elena ORCID: 0000-0002-3691-6454, Cheng, Heather H, Chi, Kim N, Chowdhury, Simon, Clarke, Caroline S, Clarke, Noel, Daugaard, Gedske, De Santis, Maria, Duran, Ignacio, Eeles, Ros, Efstathiou, Eleni, Efstathiou, Jason, Ngozi Ekeke, Onyeanunam, Evans, Christopher P, Fanti, Stefano, Feng, Felix Y, Fonteyne, Valerie, Fossati, Nicola, Frydenberg, Mark, George, Daniel, Gleave, Martin, Gravis, Gwenaelle ORCID: 0000-0002-3127-1554, Halabi, Susan ORCID: 0000-0003-4135-2777, Heinrich, Daniel, Herrmann, Ken, Higano, Celestia, Hofman, Michael S, Horvath, Lisa G, Hussain, Maha, Jereczek-Fossa, Barbara Alicja, Jones, Robert ORCID: 0000-0001-5608-001X, Kanesvaran, Ravindran, Kellokumpu-Lehtinen, Pirkko-Liisa, Khauli, Raja B, Klotz, Laurence, Kramer, Gero, Leibowitz, Raya, Logothetis, Christopher J, Mahal, Brandon A, Maluf, Fernando, Mateo, Joaquin, Matheson, David, Mehra, Niven, Merseburger, Axel, Morgans, Alicia K, Morris, Michael J, Mrabti, Hind, Mukherji, Deborah, Murphy, Declan G, Murthy, Vedang, Nguyen, Paul L, Oh, William K, Ost, Piet, O'Sullivan, Joe M ORCID: 0000-0001-6999-2739, Padhani, Anwar R, Pezaro, Carmel, Poon, Darren MC, Pritchard, Colin C, Rabah, Danny M, Rathkopf, Dana, Reiter, Robert E, Rubin, Mark A, Ryan, Charles J, Saad, Fred, Pablo Sade, Juan, Sartor, Oliver A, Scher, Howard I, Sharifi, Nima, Skoneczna, Iwona, Soule, Howard, Spratt, Daniel E ORCID: 0000-0002-5973-4741, Srinivas, Sandy, Sternberg, Cora N, Steuber, Thomas, Suzuki, Hiroyoshi, Sydes, Matthew R ORCID: 0000-0002-9323-1371, Taplin, Mary-Ellen, Tilki, Derya, Türkeri, Levent, Turco, Fabio, Uemura, Hiroji, Uemura, Hirotsugu, Ürün, Yüksel, Vale, Claire L, van Oort, Inge, Vapiwala, Neha, Walz, Jochen, Yamoah, Kosj, Ye, Dingwei, Yu, Evan Y, Zapatero, Almudena, Zilli, Thomas and Omlin, Aurelius
(2023)
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022.
, Switzerland.
This list was generated on Mon Apr 22 18:18:46 2024 BST.